KOVANAZE FDA approval date

The FDA approved KOVANAZE on 29 Jun 2016.

FDA approval date
29 Jun 2016

Drug identity has not yet been verified against registry records

Also recorded as OXYMETAZOLINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-06-29DayKOVANAZEFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208032", "applicant_as_listed_by_fda": "ST RENATUS", "brand_names": ["KOVANAZE"], "active_ingredients": ["OXYMETAZOLINE HYDROCHLORIDE", "TETRACAINE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160629", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026